HALAMAN JUDUL ANALISIS EFEKTIVITAS BIAYA TERAPI PENYAKIT HIPERTENSI PADA PASIEN RAWAT INAP DI RUMAH SAKIT ISLAM KLATEN

Retno, Wulandari (2021) HALAMAN JUDUL ANALISIS EFEKTIVITAS BIAYA TERAPI PENYAKIT HIPERTENSI PADA PASIEN RAWAT INAP DI RUMAH SAKIT ISLAM KLATEN. Other thesis, Sekolah Tinggi Ilmu Kesehatan Nasional.

	Text Fulltext Retno Wulandari.pdf Restricted to Repository staff only Download (1MB)
	Text KTI.pdf Download (1MB)

Abstract

Hypertension is defined as a persistent increase in arterial blood pressure. Hypertension is a major problem for people in Indonesia and in several countries in the world. Treatment of hypertension requires a large cost, because it is carried out in a long period of time, therefore a costeffectiveness analysis is carried out in order to assist in making decisions on the selection of drugs that are effective in terms of benefits and costs. This study aims to determine the cost-effectiveness of using single and combination antihypertensive drugs at the Klaten Islamic Hospital in JanuaryDecember 2019. This study used a descriptive method with retrospective data collection with pharmacoeconomic analysis using the CEA (Cost Effectiveness Analysis) method. The data taken include: medical record data of hypertension patients, the cost of antihypertensive drugs and administrative costs of inpatient treatment at the Klaten Islamic Hospital. The sample in this study was 101 patients including 31 patients using a single antihypertensive and 70 patients using a combination antihypertensive. The analysis of the results of this study showed the percentage of therapeutic effectiveness from the use of amlodipine 77.77%, candesartan 76.47% and the combination of candesartan + amlodipine 80.00%, then calculated the average total cost of using amlodipine antihypertensive Rp.67,184.11; candesartan Rp. 87,548,53 and candesartan+amlodipine Rp. 85,524,9. The results showed that the single antihypertensive drug amlodipine was more cost-effective with an ACER value of Rp.863,88 compared to the single antihypertensive drug candesartan Rp. 1,144,87 and combination antihypertensive candesartan+amlodipine Rp. 1,069.06.

Actions (login required)

View Item